Alpek signs agreement to acquire PET facility from Lotte Chemical

| October 31, 2019

article image
Alpek announced that one of its subsidiaries has signed an agreement with Lotte Chemical Corporation to acquire a 100% stake in Lotte Chemical UK Limited, which owns and operates a 350,000 ton per year polyethylene terephthalate (“PET”) facility in Wilton, United Kingdom. "This acquisition is well-aligned with Alpek’s growth strategy, creating substantial value by integrating the asset into our global polyester footprint, marking our first acquisition outside of the Americas, and growing our current worldwide PET capacity to 2.8 million tons," said José de Jesús Valdez, Alpek’s CEO. "Moving forward, our team is focused on executing a seamless integration to capitalize on existing momentum and capture synergies." The terms of the agreement have not been disclosed, and the acquisition is expected to be completed in the fourth quarter of 2019 subject to customary government approvals.

Spotlight

Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc. is focused on specialty pharmaceuticals in dermatology and is the leading manufacturer of topical pharmaceutical products in the U.S. Over the last 8 years, we have developed over 60 FDA-approved topical therapies in the United States - more than any other company in that time frame. Fougera Pharmaceuticals Inc.'s core divisions are: PharmaDerm - PharmaDerm is a fully vertically-integrated specialty pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The PharmaDerm division of Fougera Pharmaceuticals Inc. is dedicated to bringing innovative products to dermatologists so they can best care for their patients. Fougera - E. Fougera & Company is Fougera Pharmaceuticals Inc.'s generic drug division, which primarily produces multi-source prescription and OTC dermatologic preparations. Fougera Pharmaceuticals Inc.has been ser

OTHER ARTICLES

Pandemic’s third wave seems unlikely to damage global petrochemicals demand

Article | July 22, 2021

Petrochemical stocks plunged worldwide on 19 July ahead of the Q2 earnings season. The declines were consistent with those in economically sensitive sectors such as steel, copper, automotive and housing,” wrote my ICIS colleague, Joseph Chang, in this Insight article.

Read More

Exploring the potential impact of Brexit on the chemical industry

Article | March 12, 2020

With Brexit officially underway, the UK has entered the transition period during which arrangements affecting the chemical industry will be made. The chemical sector produces around £50 billion worth of exports annually, and 60% of this goes directly to the European Union [1]. 75% of our chemical imports also come from the EU [1], making Brexit a critical time for the sector. The future of trading is yet to be established. Now is a pivotal period during which the chemical industry, stakeholders and the government need to work together to determine this future, in order to allow for a continuation of chemistry enabled growth.

Read More

How Refiners Can Capitalise on the Petrochemical Industry

Article | April 6, 2020

Do you fancy a piece of Petrochemical Pie? As the demand for refined products is falling and demand for petrochemical products is increasing, it is vital that refiners consider petrochemical integration, which offers increased flexibility and a competitive edge. Learn more below about the benefits, considerations and recent projects, and, how the double whammy of the oil price crash and the COVID-19 pandemic is affecting the petrochemical market.

Read More

What Are Fine Chemicals?

Article | March 27, 2020

The initial versions of drugs were produced by extracting substances from natural herbs and other plants. As understanding and technology in chemistry continued to grow, scientists figured out to isolate and extract a lot more individual compounds from raw materials. The complicated processes that produce these simple, pure substances form the field of fine chemistry. The chemical industry is separated into branches, with fine chemicals serving as the smallest segment of them. Its companions are commodities and specialty chemicals. Commodity chemicals are those that are mass-produced on a big scale to supply global markets. They include general compounds that are the same from supplier to supplier. Specialty chemicals usually are sold as brand name products and are advertised for their distinct qualities and their abilities to carry out functions that other chemicals cannot. They are composed of one or more fine chemicals.

Read More

Spotlight

Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc. is focused on specialty pharmaceuticals in dermatology and is the leading manufacturer of topical pharmaceutical products in the U.S. Over the last 8 years, we have developed over 60 FDA-approved topical therapies in the United States - more than any other company in that time frame. Fougera Pharmaceuticals Inc.'s core divisions are: PharmaDerm - PharmaDerm is a fully vertically-integrated specialty pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The PharmaDerm division of Fougera Pharmaceuticals Inc. is dedicated to bringing innovative products to dermatologists so they can best care for their patients. Fougera - E. Fougera & Company is Fougera Pharmaceuticals Inc.'s generic drug division, which primarily produces multi-source prescription and OTC dermatologic preparations. Fougera Pharmaceuticals Inc.has been ser

Events